Search Results
Apr 22, 2026, 10:05 ET Frontier Dermatology to Bring Expert Skin Care to the Issaquah, WA Community
bring our standard of compassionate and extensive care to this community."The Issaquah office will have two full-time providers: Matthew Gordon, MD, and Liza Hermann, PA-C. This experienced team will offer specialized care for a wide range of skin, hair, and nail conditions. Services at the clinic
More news about: Frontier Dermatology
Apr 22, 2026, 10:03 ET WORLDPAC ANNOUNCES KEYNOTE SPEAKERS FOR LARGEST AUTO TRAINING CONFERENCE IN NORTH AMERICA
Terry Bradshaw and Siri Lindley to headline biannual STX 2026 Supplier & Training Expo NATIONAL HARBOR, Md., April 22, 2026 /PRNewswire/ --
More news about: Worldpac
Apr 22, 2026, 10:00 ET RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
Riscinti, MD); Texas Tech Health El Paso (Edward Michelson, MD); University
More news about: RIVANNA
Apr 22, 2026, 10:00 ET Power Of The Plate Conference Comes to San Diego, May 14-17, 2026, Uniting Global Leaders to Advance the Future of Food, Health, and Sustainability
as the scientific voice of a global movement."The plate is not only where nourishment begins—it is where systems converge," said Scott Stoll, MD, FABFM, co-founder and Chief Medical Officer of The Plantrician Project. "What we eat influences chronic disease, environmental outcomes, and the resilience
More news about: The Plantrician Project
Apr 22, 2026, 09:07 ET Harris Teeter Associates Volunteer Across Seven Markets for National Volunteer Week
Central and Eastern NCCharleston, SCTrident United WayLowcountry Food BankBaltimore, MDMaryland Food BankWashington, D.C.Capital Area Food BankFor more information,
More news about: Harris Teeter
Apr 22, 2026, 09:03 ET IMAGE Skincare Introduces New Additions to IMAGE MD® Medical-Grade Skincare Line
IMAGE MD® collection with three new clinically proven formulas. The launches build upon the existing award-winning IMAGE MD® lineup, reinforcing the collection's focus on advanced, results-driven anti-aging
More news about: IMAGE Skincare
Apr 22, 2026, 09:02 ET Sleep Medicine Physician Dr. Funke Afolabi-Brown Launches Online Insomnia Program, Joins HumanUp as Expert Sleep Partner
https://www.prnewswire.com/news-releases/sleep-medicine-physician-dr-funke-afolabi-brown-launches-online-insomnia-program-joins-humanup-as-expert-sleep-partner-302749771.htmlSOURCE Restful Sleep MD
More news about: Restful Sleep MD
Apr 22, 2026, 09:00 ET MDVIP Appoints Jeffrey Lin, MD, FACC, as Chief Medical Officer
multimedia:https://www.prnewswire.com/news-releases/mdvip-appoints-jeffrey-lin-md-facc-as-chief-medical-officer-302750274.htmlSOURCE
More news about: MDVIP
Apr 22, 2026, 09:00 ET Choice Hotels' Canadian Business Achieves Best First Quarter Growth in a Decade Following Successful Integration
NORTH BETHESDA, Md., April 22, 2026 /PRNewswire/ -- Choice Hotels International, Inc. (NYSE: CHH), one of the world's largest lodging franchisors, today shared an update on its Canadian business, highlighting continued momentum
More news about: Choice Hotels International, Inc.
Apr 22, 2026, 09:00 ET Phanes Therapeutics to Present Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
- Gastroesophageal, Pancreatic, and HepatobiliaryAbstract #: 4192Poster #: 175First Author: Anwaar Saeed, MD, University of Pittsburgh Medical CenterABOUT SPEVATAMIGSpevatamig is a first-in-class native IgG-like bispecific antibody (bsAb)
More news about: Phanes Therapeutics, Inc.
Apr 22, 2026, 08:53 ET $500,000 Michael F. Price Memorial Grant from DeGregorio Family Foundation Awarded for Novel Gastroesophageal Cancer Therapy
The DeGregorio Family Foundation with support from the Torrey Coast Foundation has awarded $250,000 to Timothy C. Wang, MD, Chief, Division of Digestive and Liver Diseases, Silberberg Professor of Medicine, Department of Medicine and Irving Cancer Research Center, Columbia
More news about: DeGregorio Family Foundation
Apr 22, 2026, 08:32 ET LACI Launches Second City Climate Innovation Challenge with Baltimore, Atlanta, Chicago, San Francisco, Portland, NYC, LA, and 9 Others, Representing 1 in 5 Americans; New Cohort Will Identify and Deploy Innovations to Help Accelerate More Affordable, Reliable Clean Energy and EV Charging Solutions
with other cities."The 16 cities of the second Cohort include:Alexandria, Va.Atlanta, Ga.Baltimore, Md.Chicago, Ill.Hayward, Calif.Knoxville, Tenn.Los Angeles, Calif.New York, N.Y.Palo Alto, Calif.Portland,
More news about: LACI
Apr 22, 2026, 08:30 ET Chronic Inflammatory Dermatoses: Designing Trials for Late-Stage Success, Upcoming Webinar Hosted by Xtalks
Register for this webinar to learn how the inflammatory dermatoses trial design can support late-stage success.Join Ayman Farahat, MD, Vice President, Medical Affairs, Global Head of Dermatology,
More news about: Xtalks
Apr 22, 2026, 08:30 ET Neuroscience Drug Development: How Novel Applications of AI Could Meaningfully Disrupt Traditional Development Strategies, Upcoming Webinar Hosted by Xtalks
Clario, Todd Rudo (Moderator), MD, EVP, Chief Medical Officer; Mark Opler, PhD, Chief Research Officer, eCOA Neuroscience; Alex Boudreau, Director, AI; and Joël Schaerer, PhD, Senior Director,
More news about: Xtalks
Apr 22, 2026, 08:06 ET Ada Health Clinical AI Turns Symptom Uncertainty Into Appropriate Action, Finds NEJM AI Study Conducted with CUF in Portugal
immediately, the evidence is clear: they navigate to the right care. That has real consequences for real people."— Dr. Micaela Seemann Monteiro, MD, Chief Medical Officer for Digital Transformation, CUFActivating Appropriate ActionThe central finding of this
More news about: Ada Health
Apr 22, 2026, 08:05 ET IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)
"For people living with gMG, consistent and durable symptom control is the central goal of treatment," said Constantine Farmakidis, MD, Associate Professor of Neurology at the University of Kansas Medical Centerc. "These long-term results, now extending to beyond two years,
More news about: Johnson & Johnson
Apr 22, 2026, 08:00 ET Thryv Therapeutics Commences Patient Dosing in Wave II Clinical Study for Long QT Syndrome and Receives FDA Fast Track Designation for THRV-1268
by change in QTcF over six hours, together with evaluations of cardiac rhythm stability, safety, and tolerability.Professor Vasanth Vedantham, MD, PhD, at UCSF Health in San Francisco, California, initiated the first of fourteen patients planned in Part A of the Wave II study."The
More news about: Thryv Therapeutics Inc.
Apr 22, 2026, 08:00 ET Learning Without Tears Launches Get Set for School®: Letters & Literacy™ to Strengthen Early Literacy Through Play and Movement
science of reading with hands-on learning to build essential reading and writing foundationsGAITHERSBURG, Md., April 22, 2026 /PRNewswire/ -- Learning Without Tears, a leader in early literacy, today announced the development
More news about: Learning Without Tears
Apr 22, 2026, 07:00 ET Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting
taken up by cancer cells, which have a greater rate of pinocytosis (uptake of extracellular material) than normal cells. Laboratory studies conducted at MD Anderson show that the uptake of TUSC2 in tumor cells in vitro after REQORSA treatment was 10 to 33 times the uptake in normal cells. Biopsies in three
More news about: Genprex, Inc.
Apr 22, 2026, 06:00 ET Mosaic Raises $18M Series A To Build AI-Driven Operating System For Deal Makers
via an emailed prompt to Mosaic's agent, "Mo," who ingests supporting documents (including CIMs), applies firm-specific defaults, and generates an "MD-ready" model in an email reply within 5 minutes."When I worked in Investment Banking and Private Equity, I was always shocked at how much time some
More news about: Investor Technology Group, Inc.
Apr 22, 2026, 06:00 ET Mosaic Raises $18M Series A To Build AI-Driven Operating System For Deal Makers
via an emailed prompt to Mosaic's agent, "Mo," who ingests supporting documents (including CIMs), applies firm-specific defaults, and generates an "MD-ready" model in an email reply within 5 minutes."When I worked in Investment Banking and Private Equity, I was always shocked at how much time some
More news about: Investor Technology Group, Inc.
Apr 22, 2026, 05:27 ET American Parkinson Disease Association Welcomes Three Distinguished Leaders to National Board of Directors
to announce the appointment of three accomplished leaders to its National Board of Directors: Howard Lenn, Madeleine Shea, PhD, and Sara Whittingham, MD. Each brings unique expertise and a powerful perspective that will help advance APDA's mission to provide the support, education, research, and community
More news about: American Parkinson Disease Association, Inc.
Apr 21, 2026, 20:00 ET Innovent to Present New Clinical Data of IBI363（PD-1/IL-2α-biased bispecific fusion protein） at the 2026 ASCO Annual Meeting
in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Roche, Takeda, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry
More news about: Innovent Biologics
Apr 21, 2026, 17:30 ET In HelloNation, Home Insurance Expert Glenda Martinez of Silver Spring, MD, Explains Water Damage and Sewer Backup Coverage
SILVER SPRING, Md., April 21, 2026 /PRNewswire/ -- What does a typical homeowner's insurance policy actually cover when water damages your home?
More news about: HelloNation
Apr 21, 2026, 16:53 ET GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
many cancers unscreened. In the U.S., more than 70 percent of cancer deaths are from cancers without recommended screening tests," said Josh Ofman, MD, MSHS, President of GRAIL. "These results from NHS-Galleri and PATHFINDER 2, two large, rigorous studies, underscore Galleri's strong performance, ability
More news about: GRAIL, Inc.